Hey There : )
Unlisted Shares
Price Chart
1W
1M
1Y
MAX
High
-
Low
-
Return
-
Pharmeasy Essentials
As of September 18, 2024, API Holdings (Pharmeasy), Unlisted share price is ₹9.00 per share and the face value is ₹1.00/share. The lot size of API Holdings (Pharmeasy) is 22340 shares. The 52-week high for API Holdings (Pharmeasy) stock price is ₹15, while the 52-week low is ₹8
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
It is the final profit left over after subtracting all operating and non operating items from net revenue.
It is the profit allocated to each outstanding share of common stock.
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
It measures companys total value, which includes market capitalization, debt and excludes cash.
It calculates the per share value of a company based on its equity available to common shareholders
Intrinsic value is the anticipated value of a company or stock determined through fundamental analysis. It is also referred to as the price a rational investor is willing to pay for an investment, given its level of risk.
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category is defined as a class or division of things regarded as having particular shared characteristics.
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
It shows the net flows of cash that are used to fund the company, which include transactions involving debt, equity, and dividends.
Average traded price is the average price at which a stock trades over a period of time.
Pharmeasy Growth
Compounded Sales Growth
Return On Equity
Highlights
- E-Pharmacy Market Leader - API Holdings Limited, through its subsidiaries, develops and operates an integrated digital healthcare platform. The company offers teleconsultation; diagnostics and radiology tests; and Redbook, an enterprise resource planning (ERP) and pharmacy customer relationship management software. The company operates a consumer healthcare app called PharmEasy which enables on-demand, home delivery of pharmaceutical products to customers.
- Revenue Growth - The company's revenue has experienced a substantial rise, climbing from ₹5,728 Cr in FY22 to ₹6,643 Cr in FY23, indicating a growth rate of 17.3%. Over the past three years, the company's revenue has consistently increased, achieving a compound annual growth rate (CAGR) of 118% from FY20 to FY23.
- Profitability - The company's profitability has worsened over time. The EBIT margin, which was -44.3% in FY22, has improved to -25.1% in FY23, reflecting an improvement of 43.6%. The net profit margin of the company has further deteriorated from -70.7% in FY22 to 78.6% in FY23, demonstrating a decrease of 11.2% from FY22 to FY23.
- Notable Investors - PharmEasy has attracted several prominent investors throughout its journey, with the current landscape looking a bit different from its peak valuation days. Some of the notable investors include TPG Group, Naspers Ventures, Kotak, Goldman Sachs, MacRitchie Investments, and Ivy Icon Solutions. Manipal Group, the Indian healthcare conglomerate is set to become the single largest shareholder with a potential 18% stake, marking a significant development in PharmEasy's funding picture.
- Investment Thesis - PharmEasy recently encountered a substantial 90% reduction in its valuation following a violation of crucial loan terms established by Goldman Sachs. To address this, PharmEasy intends to generate approximately ₹2,400 Cr through a rights issue, offering shares at a 90% discounted valuation. The rights issue is set at a valuation of around $800 million, with a per-share price of ₹5.
- PharmEasy, previously valued at $5.6 billion with a share price of ₹130, has undergone a substantial correction, now standing at $800 million, marking an approximately 85% reduction. The positive shift in margins and the active involvement of the Manipal Group in the rights issue signify a potential turning point for the company. The Manipal Group's expertise in the healthcare sector adds a strategic vision to the company's trajectory.
Business Rating
Our Team
Hardik Dedhia is a Co-Founder of our Company. He joined Ascent Health and Wellness Solutions Private Limited, which merged into our Company pursuant to Merger 2020, as the Chief Technical Officer on April 1, 2016.
Harsh Parekh is a Co-founder and Whole-time Director of our Company. He holds a master’s degree in business administration from the School of Business Management, Narsee Monjee Institute of Management Studies, Mumbai.
₹
Quantity
Invest
₹
Min. Investment: ₹